Cannabis legalization group DCMJ co-founders Adam Eidinger and Nikolas Schiller spoke their piece in a half hour meeting at the White House Monday afternoon, and want to return soon to meet with "higher-level" officials.
The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.